dimecres, 24 de setembre del 2014

TAVI: Boston Scientific launches U.S. Lotus valve trial




Boston Scientific launches a U.S. clinical trial of its Lotus transcatheter aortic valve implant in high-and extreme-risk patients.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xfMsm6

Cap comentari:

Publica un comentari a l'entrada